News

Time is Running Out to Give Blood and Get Free Zoo Admission

08/01/2017
Time is Running Out to Give Blood and Get Free Zoo Admission
Donors who save lives by giving blood with Oklahoma Blood Institute will receive a pass for two to the Oklahoma City Zoo and a free “Keep It Local” t-shirt through the month of August.* Join Tinker AFB Exchange at a blood drive with Oklahoma Blood Institute from 8 a.m. to Noon, Friday, Aug. 4 on the bloodmobile at 3360 N. Avenue, Bldg 685. Healthy adults**, age 16 and older, can give blood. Read More

Blood Donors Who Give at Bob Moore Auto Group Drive Have a Chance to Win a Car – Saturday, August 12

08/01/2017
Blood Donors Who Give at Bob Moore Auto Group Drive  Have a Chance to Win a Car – Saturday, August 12
One lucky donor who gives blood at selected Bob Moore Auto Group dealerships across the metro will drive away with a brand new Buick Verano. Bob Moore Auto Group is teaming up with Oklahoma Blood Institute and KFOR-TV to hold blood drives on Saturday, August 12, from 8:00 a.m. to 6:00 p.m. Read More

Oklahoma researchers zero in on cause of blood disorder

07/26/2017
Scientists at the Oklahoma Medical Research Foundation have found new clues about the origins of a bleeding disorder. Read More

Children With Life-Threatening Illnesses Take Off For Specialized Camp

07/25/2017
More than 100 campers with life-threatening illnesses are boarding buses at The Children’s Hospital at OU Medical Center to enjoy four days of excitement at Camp Cavett near Lake Texoma. They will be joined by almost 200 volunteers at Cross Point Camp near Kingston, Oklahoma, to relax, make friends and participate in activities that organizers say can be a life-changing experience. The camp provides nurses and doctors to ensure medical needs are provided so kids can kick back and just be kids. Read More

OMRF collaborates with GSK to develop novel treatments for severe inflammatory diseases

07/24/2017
OMRF collaborates with GSK to develop novel treatments for severe inflammatory diseases
The Oklahoma Medical Research Foundation (OMRF) has signed a collaboration agreement with GSK, one of the world’s leading healthcare companies, for the discovery, development and commercialization of novel therapies to prevent organ damage and death caused by conditions such as acute pancreatitis, lung injury and trauma. Read More

Oklahoma Blood Institute Needs Summer Lifesavers

07/20/2017
Oklahoma Blood Institute Needs Summer Lifesavers
Healthy adults*, age 16 and older, can give blood at one of the following drives: First Baptist Church Newalla, 20800 SE 59th Street, Sunday, July 30, in the Gym, from 1:00 p.m. to 3:30 p.m.; BancFirst, 19979 NE 23rd Street, Harrah, Monday, July 31, on the Bloodmobile, from 1:30 p.m. to 4:30 p.m. Read More

International study reveals 24 new genes associated with lupus

07/20/2017
A nine-year research study has identified two dozen new genes linked to the autoimmune disease lupus. Read More

Oklahoma Blood Institute Needs Summer Lifesavers

07/18/2017
Oklahoma Blood Institute Needs Summer Lifesavers
Oklahoma Blood Institute is looking for summer lifesavers to save three lives with one blood donation. Read More

Notice of Public Comment Period for Oklahoma Section 1332 State Innovation Waiver

07/18/2017
The Oklahoma Health and Human Services Cabinet Secretary (HHS), in conjunction with the Oklahoma Insurance Department (OID), has developed a 1332 State Innovation Waiver pursuant to House Bill 2406 to create a Market Stabilization Program to waive certain provisions of the Affordable Care Act (ACA), assume state control and regulation of the Oklahoma individual health insurance market, increase competition, reduce healthcare premiums and protect coverage for approximately 130,000 Oklahomans. Read More

OMRF researcher tests new approach for treating deadly blood infection

07/18/2017
OMRF researcher tests new approach for treating deadly blood infection
Oklahoma Medical Research Foundation scientist Florea Lupu, Ph.D., has tested a novel way to inhibit cellular processes during sepsis that could lead to the development of new therapies for the deadly condition. Read More

Get the Newsletter